Thilo Werner
GlaxoSmithKline (Germany)(DE)
Publications by Year
Research Areas
PARP inhibition in cancer therapy, Biosimilars and Bioanalytical Methods, Ubiquitin and proteasome pathways, Protein Degradation and Inhibitors, Health Systems, Economic Evaluations, Quality of Life
Most-Cited Works
- → Tracking cancer drugs in living cells by thermal profiling of the proteome(2014)1,179 cited
- → Computational prediction of proteotypic peptides for quantitative proteomics(2006)690 cited
- → Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry(2015)684 cited
- → Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation(2020)416 cited
- → Thermal proteome profiling monitors ligand interactions with cellular membrane proteins(2015)309 cited
- → Meltome atlas—thermal proteome stability across the tree of life(2020)286 cited
- → Ion Coalescence of Neutron Encoded TMT 10-Plex Reporter Ions(2014)274 cited
- → Proteome-wide solubility and thermal stability profiling reveals distinct regulatory roles for ATP(2019)272 cited
- → Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia(2021)262 cited
- → Thermal profiling reveals phenylalanine hydroxylase as an off-target of panobinostat(2016)252 cited